science

SN-38

SN-38 is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand SN-38 rather than just read about it. In short: SN-38 is an antineoplastic drug. It is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor) but has 1000 times more activity than irinotecan itself.

Key takeaways

SN-38 belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect SN-38 to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of SN-38 from memory before moving on to harder problems.

Reference excerpt

SN-38 is an antineoplastic drug. It is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor) but has 1000 times more activity than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN-38 relative to irinotecan varies from 2- to 2000-fold. SN38 is formed via hydrolysis of irinotecan by carboxylesterases and metabolized via glucuronidation by UGT1A1. The variant of UGT1A1 in ~10% of Caucasians which leads to poor metabolism of SN-38 predicts irinotecan toxicity, as it is then less easily excreted from the body in its SN-38 glucuronide form. SN-38 and its glucuronide are lost into the bile and intestines. It can cause the symptoms of diarrhoea and myelosuppression experienced by ~25% of the patients administered irinotecan.

Use in antibody-drug conjugates SN-38 has been utilized as the cytotoxic payload in the antibody-drug conjugate (ADC) sacituzumab govitecan. Unlike ADCs that employ ultra-toxic payloads with picomolar IC50 values, SN-38 is considered a moderately toxic agent with IC50 in the nanomolar range, potentially allowing for a lower off-target toxicity profile. In sacituzumab govitecan, SN-38 is conjugated to an anti-Trop2 antibody via a cleavable CL2A linker, achieving a high drug-to-antibody ratio (DAR) of approximately 7.6. This high DAR allows for efficient delivery of the chemotherapeutic agent to tumor cells. The cleavable linker also facilitates the release of SN-38 in both the extracellular space and the cytoplasm. Once released, SN-38's membrane permeability enables it to diffuse out of target cancer cells and exert cytotoxic effects on neighboring cells regardless of their Trop2 expression status, a phenomenon known as the "bystander killing effect".

Interactive pathway map Click on genes, proteins and metabolites below to link to respective articles.

See also NK012, a nanodevice formulation of SN-38 Sacituzumab govitecan, an antibody-drug conjugate that uses SN-38 as the cytotoxic drug.

References

Illustrations

Worked examples

Example 1 — a first encounter with SN-38

Start with the simplest possible case. Write down what SN-38 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to SN-38 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about SN-38 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of SN-38

In research: SN-38 appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses SN-38 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: SN-38 is common in secondary-school and first-year university syllabi. It links to neighbouring topics Oncology stubs, Topoisomerase inhibitors, so understanding it makes those chapters shorter.
In everyday life: Look for SN-38 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “SN-38” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study SN-38 in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what SN-38 means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain SN-38 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is SN-38 in simple terms?

SN-38 is an antineoplastic drug. It is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor) but has 1000 times more activity than irinotecan itself.

Why does SN-38 matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study SN-38?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on SN-38.